Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 102   

Articles published

THRX 9.08 +0.05 (0.55%)
price chart
Should You Buy Theravance Inc (THRX)?
Is Theravance Inc (NASDAQ:THRX) a bargain? Investors who are in the know are becoming hopeful. The number of bullish hedge fund bets advanced by 9 in recent months.
Why Need to Watch: Theravance Inc. (NASDAQ:THRX), Skyworks Solutions Inc ...  Benchmark Monitor
Will Theravance Incorporated (NASDAQ:THRX) beat previous EPS of -0.34?  The Bulletin
Theravance, Inc. Short Interest Update
Theravance, Inc. (NASDAQ:THRX) stated loss of 889,053 shares or 3.5% in the short interest. The short interest registered from 25,771,944 on October 30,2015 to 24,882,891 on November 13,2015.
Why Theravance Inc. Vaulted 15% Higher in October
Count me in the group that applauds this capital allocation decision, as a share repurchase program gives the company far more financial flexibility than an ongoing dividend payment.
Why Theravance Inc. Shares Crashed 21% Today
So what: Theravance is the company behind GlaxoSmithKline's (NYSE:GSK) Relvar/Breo Ellipta drug for the treatment of chronic obstructive pulmonary disease, or COPD.
Theravance Just Lost Its Catalyst  Benzinga
Theravance, Glaxo SUMMIT Study Misses Primary Endpoint
Theravance, Inc. Announces Commencement of Self-Tender Offer for up to ...
SOUTH SAN FRANCISCO, CA, Oct 30, 2015 (Marketwired via COMTEX) -- Theravance, Inc. THRX, -0.34% today announced that it is commencing its previously announced "modified Dutch auction" tender offer for up to $75,000,000 of its common stock at a ...
Theravance, Inc. Announces Commencement of Self-Tender Offer for up to ...  CNNMoney
Company Shares of Theravance, Inc. (NASDAQ:THRX) Rally 0.68%
Shares of Theravance, Inc. (NASDAQ:THRX) rose by 0.68% in the past week and 0.22% for the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 2.51%.
Company Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) Rally 1.9%  OTC Outlook
Analysts Set Theravance Target Price at $12.17 (NASDAQ:THRX)  Dakota Financial News
Price Target Update on Theravance, Inc. (NASDAQ:THRX)
Theravance, Inc. (NASDAQ:THRX) shares are expected to touch $11 in the short term. This short term price target has been shared by 4 analysts.
Price Target Update on Theravance Biopharma, Inc. (NASDAQ:TBPH)  Insider Trading Report
Theravance Given Consensus Rating of "Hold" by Analysts (NASDAQ:THRX)  Dakota Financial News
Why Shares of Theravance Inc Sank 12% in July
Despite reporting a net loss, Theravance continued paying a generous dividend of $0.25 per share. The huge dividend and interest payments continue to take its toll on the company's cash balance, which once again dropped and now stands at $229 million.
Theravance, Inc. Analyst Rating Update
Theravance, Inc. (NASDAQ:THRX) has received a short term rating of hold from research analysts at Zacks with a rank of 3. The company has been rated an average of 3.46 by 5 Wall Street Analysts.
Theravance, Inc. (NASDAQ:THRX) Short Interest Update
Theravance, Inc. (NASDAQ:THRX) saw a drop of 2.8% or -752,496 shares in the short positions. The number dropped from 26,524,440 on October 15,2015 to 25,771,944 on October 30,2015.
Notable Session Mover: Theravance, Inc. (NASDAQ:THRX)  Vanguard Tribune
Can Theravance Incorporated hit Expected Sales of 15.001M?  The Bulletin